MAMallika Alexander

Mallika Alexander

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Mallika Alexander has a total of 75 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Gestational Diabetes Awareness Is Low Among Low‐Income Pregnant Women Attending a Public Antenatal Clinic in Pune, India

    by Hannah Lee, Saanya Agarwal, Priyanka Raichur, Vedika Potphode, Mallika Alexander, Aditi Kole, Sanjaykumar Tambe, Shilpa Naik, Puja Chebrolu, Jyoti S. Mathad

    Objective: Gestational Diabetes (GDM) is increasingly common and associated with adverse outcomes, yet awareness remains low in many settings. We examined factors associated with GDM awareness among low and middle‐income pregnant women in India. Methods: Pregnant women were enrolled at a government hospital in Pune, India. Participants were asked if they had heard of diabetes and, if so, completed a 12‐item questionnaire assessing knowledge of GDM risk factors, testing and treatment, and consequences. Each correct response scored 1 point; scores of 0–4 were classified as poor awareness, 5–8 as fair, and 9–12 as good. Suboptimal awareness was defined as poor, fair, or no awareness. A multivariable logistic regression was used to assess risk factors for suboptimal awareness. Results: Among 368 women, median age was 25 years (IQR 22–29), gestational age 20.4 weeks (IQR 16.5–24.0), BMI 22.8 kg/m 2 (IQR 20–26.9); 33% ( n = 122) were primigravid, 31% ( n = 114) living with HIV, and 11% ( n = 41) had GDM. Among 326 (89%) of women who were aware of diabetes, median GDM awareness score was 9 (IQR 7–10). Overall, 197/368 (54%) women had suboptimal awareness. On multivariable analysis adjusting for residence, gravidity, and BMI, living with HIV (aOR 1.7, 95% CI 1.0–2.8, p = 0.04) and lower socioeconomic status (aOR 1.9, 95% CI 1.1, 3.2) were independently associated with odds of suboptimal GDM awareness. Conclusions: GDM awareness remains suboptimal among low‐income pregnant women in India, particularly among women with HIV. Targeted educational health interventions may improve awareness and reduce long‐term complications.

  • Open Access

    Dolutegravir Is Associated With Lower Odds of Gestational Diabetes Compared to Other Antiretroviral Therapy Regimens Among Pregnant Women in India: A Cross‐Sectional Analysis

    by Puja Chebrolu, Farheen Ahmed, Sanjaykumar Tambe, Mallika Alexander, Priyanka Raichur, Aditi Kole, Sonali Kante, Vandana Kulkarni, Nikhil Gupte, Ramesh Bhosale, et al.

    Introduction: In non‐pregnant adults living with HIV, dolutegravir is associated with weight gain and increased type 2 diabetes risk. In pregnancy, data on the effect of dolutegravir on gestational diabetes (GDM) risk is inconclusive. Data are particularly limited in Asian populations, where diabetes risk is especially high and not always associated with weight gain. We examined the association of dolutegravir with GDM among women living with HIV in India. Methods: We combined data from two cohorts of pregnant women living with HIV conducted at BJ Government Medical College in Pune, India—the PRACHITi study (2016−2019) and the PRAGATHi study (2023−present). Women were screened for GDM with the fasting 2‐h 75 g oral glucose tolerance test and diagnosed by World Health Organization criteria. Demographics, anthropometrics, antiretroviral therapy (ART), CD4 count and HIV viral load were collected at screening. Multivariate logistic regression was used to determine the association between current dolutegravir use and GDM. Results: Of 254 women living with HIV, 99.2% ( n = 252) were on ART, of whom 66.3% ( n = 167) were on dolutegravir‐, 22.6% ( n = 57) were on efavirenz‐ and 6.3% ( n = 16) were on protease inhibitor (PI)‐based ART. Overall, median CD4 count was 549.5 cells/mm 3 (IQR 401−753), and 82.2% ( n = 198) had undetectable viral load. Median body‐mass index (BMI) was 21.3 kg/m 2 (IQR 19.4−23.8). The prevalence of GDM was 11.8% ( N = 30). Among women on dolutegravir‐based ART, the prevalence was 10.8% ( N = 18); among women on efavirenz‐based ART, the prevalence was 12.3% ( N = 7), and the prevalence was 25% ( N = 4) among women on PI‐based ART. Compared to women not taking dolutegravir, women taking dolutegravir had similar age and BMI but greater weight gain from the second to the third trimester (3.7 vs. 2.9 kg, p p 2 , 95% CI 1.1−1.3) were also associated with GDM. Conclusions: Women on dolutegravir had lower odds of GDM compared to women taking other ART, despite greater weight gain. Ongoing studies are investigating the possible anti‐inflammatory mechanisms.

  • Open Access

    Impact of maternal HIV infection on the gut microbiome and metabolome of mothers and infants: the PRACHITi cohort in Pune, India

    by Jenna Mandell, Tian Wang, Jyoti S. Mathad, Mehr Shafiq, Shilpa Naik, Mallika Alexander, Vandana Kulkarni, Prasad Deshpande, Michael S. Humphrys, Bing Ma, et al.

    Human immunodeficiency virus (HIV) affects millions of reproductive-age women globally, and during pregnancy is associated with adverse birth and infant health outcomes. Research on how maternal HIV shapes the gut microbiota, a potentially modifiable factor, during pregnancy, postpartum, and in infancy remains limited. The PRACHITi cohort study was conducted in India among 244 pregnant women with and without HIV, who were followed along with their children through 1 year postpartum. Our study focuses on secondary objectives of the PRACHITi study related to gut microbiota, with longitudinal samples being collected in the full cohort and more frequent sampling in a sub-study. Here, our findings reveal gut dysbiosis (based on 16S rRNA sequencing) and distinct plasma metabolomic profiles across pregnancy, postpartum, and their infants among women with HIV compared with seronegative women. We show that specific taxa and metabolites are differentially abundant by HIV status, some of which are linked to adverse outcomes, including preterm birth, low birth weight, and inflammation, conditions that are more common among populations with HIV. These results suggest potential biological pathways through which HIV affects maternal and infant health.


  • Open Access

    HIV-related Differences in Placental Immunology: Data From the PRACHITi Cohort in Pune, India

    by Jyoti S Mathad, Mallika Alexander, Ramesh Bhosale, Shilpa Naik, Lisa Marie Cranmer, Vandana Kulkarni, Sydney Busch, Andrea Chalem, Emily Gitlin, Jun Lei, et al.

    Background: Maternal HIV infection can affect placental immunology and expression of the neonatal crystallizable fragment receptor (FcRn), which allows transplacental antibody transfer. This study delineated differences in placental FcRn and T-cell expression by HIV status, with or without viral suppression. Methods: This observational cohort study in Pune, India, followed pregnant women with and without HIV through 1 year postpartum; 42 had placenta collected, stratified by HIV status. FcRn expression was analyzed by Western blot (normalized by GADPH) and compared using ImageJ. Placental CD4/CD8 abundance was assessed by immunofluorescent counting per high powered field. Results: The median gestational age at delivery was 38.3 weeks (interquartile range [IQR] 37.5–39.1). Of 18 women living with HIV, all were on combined antiretroviral therapy with a median CD4 of 455 cells/mm3 (IQR 281–640) at entry and 429 cells/mm3 (IQR 317–686) at delivery. Ten had undetectable virus (≤40 copies/mL); of those with detectable virus, the median viral load was 151 copies/mL (IQR 118.15–539 334). Relative placental FcRn expression was lower in women living with HIV compared to without (median 0.54 vs 0.84, P = .01) and not associated with CD4 or viral load. Women with HIV had significantly higher abundance of placental CD8+ T cells, regardless of viral suppression, compared to women without. Conclusions: Maternal HIV, even with viral suppression, is associated with lower placental FcRn expression and increased placental CD8+ T cells. These results suggest that dysregulation may not be completely reversed by antiretroviral therapy and could contribute to poorer infant outcomes, even in the absence of mother-to-child HIV transmission.


  • Open Access

    Clinically relevant antibiotic resistance genes are linked to a limited set of taxa within gut microbiome worldwide

    by Peter J. Diebold, Matthew W. Rhee, Qiaojuan Shi, Nguyen Vinh Trung, Fayaz Umrani, Sheraz Ahmed, Vandana Kulkarni, Prasad Deshpande, Mallika Alexander, Ngo Thi Hoa, et al.

    The acquisition of antimicrobial resistance (AR) genes has rendered important pathogens nearly or fully unresponsive to antibiotics. It has been suggested that pathogens acquire AR traits from the gut microbiota, which collectively serve as a global reservoir for AR genes conferring resistance to all classes of antibiotics. However, only a subset of AR genes confers resistance to clinically relevant antibiotics, and, although these AR gene profiles are well-characterized for common pathogens, less is known about their taxonomic associations and transfer potential within diverse members of the gut microbiota. We examined a collection of 14,850 human metagenomes and 1666 environmental metagenomes from 33 countries, in addition to nearly 600,000 isolate genomes, to gain insight into the global prevalence and taxonomic range of clinically relevant AR genes. We find that several of the most concerning AR genes, such as those encoding the cephalosporinase CTX-M and carbapenemases KPC, IMP, NDM, and VIM, remain taxonomically restricted to Proteobacteria. Even cfiA, the most common carbapenemase gene within the human gut microbiome, remains tightly restricted to Bacteroides, despite being found on a mobilizable plasmid. We confirmed these findings in gut microbiome samples from India, Honduras, Pakistan, and Vietnam, using a high-sensitivity single-cell fusion PCR approach. Focusing on a set of genes encoding carbapenemases and cephalosporinases, thus far restricted to Bacteroides species, we find that few mutations are required for efficacy in a different phylum, raising the question of why these genes have not spread more widely. Overall, these data suggest that globally prevalent, clinically relevant AR genes have not yet established themselves across diverse commensal gut microbiota.


  • The Association of Gestational Diabetes with HIV Infection and Tuberculosis in Indian Women

    by Puja Chebrolu, Mallika Alexander, Ramesh Bhosale, Shilpa Naik, Nikhil Gupte, Myung Hee Lee, Pavan Kumar, Subash Babu, Daniel W. Fitzgerald, Amita Gupta, et al.

    : Infection of HIV is associated with an increased diabetes risk, which also increases tuberculosis risk. It is unknown if similar associations exist with gestational diabetes (GDM). We screened pregnant women living with and without HIV for GDM using oral glucose tolerance testing. In a subgroup of women with latent tuberculosis (positive interferon-gamma [IFN-γ] release assay), we used supernatants from tuberculosis antigen tubes to compare cytokine levels from women with and without GDM, matched by age and HIV status. Of 234 women, 21 (9%) had GDM, 13.9% living with HIV, and 6.5% without HIV (P = 0.06). Compared with women without GDM, women with GDM had lower median IFN-γ (19.1 versus 141.9 pg/mL, P = 0.03) and interleukin-2 (18.7 versus 249 pg/mL, P < 0.01). Our study suggests that HIV infection is associated with an increased risk of GDM, which is associated with decreased Mycobacterium tuberculosis immune responses. Gestational diabetes screening should be prioritized in tuberculosis-endemic countries, especially in women living with HIV.


  • Open Access

    Validation of New Interactive Nutrition Assistant - Diet in India Study of Health (NINA-DISH) FFQ with multiple 24-h dietary recalls among pregnant women in Pune, India

    by Kripa Rajagopalan, Mallika Alexander, Shilpa Naik, Nikhil Patil, Shivani Mehta, Cheng-Shiun Leu, Ramesh Bhosale, Jyoti S. Mathad, Laura E. Caulfield, Amita Gupta, et al.

    Adequate dietary intake is critical to prevent adverse pregnancy outcomes. India has a high burden of maternal and child morbidity and mortality, but there is a lack of adequate tools to assess dietary intake. We validate an FFQ, New Interactive Nutrition Assistant - Diet in India Study of Health (NINA-DISH), among pregnant women living with and without HIV in Pune, India. Women were selected from a cohort study investigating immune responses to HIV and latent tuberculosis during pregnancy. The FFQ was administered during the third trimester and validated against multiple 24-h dietary recalls (24-HDR) collected in second and third trimesters. Data for analysis were available from fifty-eight women out of seventy enrolled into this sub-study, after excluding those with incomplete data or implausible energy intake. The median (Q1, Q3) age of study participants was 23 (20, 25) years. Median (Q1, Q3) daily energy intakes were 10 552 (8000, 11 958) and 10 673 (8510, 13 962) kJ by 24-HDR and FFQ, respectively, with FFQ overestimating nutrient intake. Pearson correlations between log-transformed estimates from FFQ and 24-HDR for energy, protein, carbohydrate, fat, Fe and Zn were 0·47, 0·48, 0·45, 0·33, 0·4 and 0·54, respectively. Energy-adjusted and de-attenuated correlations ranged from 0·41 (saturated fat) to 0·73 (Na). The highest misclassification into extreme tertiles was observed for fat (22 %), saturated fat (21 %) and Na (21 %). Bias existed at higher intake levels as observed by Bland–Altman plots. In conclusion, NINA-DISH is a valid and feasible tool for estimating dietary intakes among urban pregnant women in Western India.


  • Open Access

    Association of Vegetable and Animal Flesh Intake with Inflammation in Pregnant Women from India

    by Su Yadana, Sameera A. Talegawkar, Jyoti S. Mathad, Mallika Alexander, Kripa Rajagopalan, Pavan Kumar, Shilpa Naik, Cheng-Shiun Leu, Vandana Kulkarni, Prasad Deshpande, et al.

    In pregnant women, studies are lacking on the relationship of vegetable and animal flesh (poultry, red meat and seafood) intake with inflammation, especially in low- and middle-income countries. We conducted a cohort study of pregnant women receiving antenatal care at BJ Medical College in Pune, India. The dietary intake of pregnant women was queried in the third trimester using a validated food frequency questionnaire. Twelve inflammatory markers were measured in plasma samples using immunoassays. Only 12% of the study population were vegetarians, although animal flesh intake levels were lower compared to Western populations. In multivariable models, higher intakes of total vegetables were associated with lower levels of the T-helper (Th) 17 cytokine interleukin (IL)-17a (p = 0.03) and the monocyte/macrophage activation marker soluble CD163 (sCD163) (p = 0.02). Additionally, higher intakes of poultry were negatively associated with intestinal fatty-acid binding protein (I-FABP) levels (p = 0.01), a marker of intestinal barrier dysfunction and Th2 cytokine IL-13 (p = 0.03), and higher seafood was associated with lower IL-13 (p = 0.005). Our data from pregnant women in India suggest that a higher quality diet emphasizing vegetables and with some animal flesh is associated with lower inflammation. Future studies should confirm these findings and test if modulating vegetables and animal flesh intake could impact specific aspects of immunity and perinatal health.


  • Open Access

    Is there a connection between gestational diabetes mellitus, human immunodeficiency virus infection, and tuberculosis?

    by M. Alexander, A. Gupta, J. S. Mathad

    Pregnancy is associated with insulin resistance similar to that found in type 2 diabetes mellitus (DM). The prevalence of gestational diabetes mellitus (GDM) in key tuberculosis (TB) endemic countries, such as India and China, has been increasing rapidly in the last decade and may be higher in human immunodeficiency virus (HIV) infected women. Pregnancy is also an independent risk factor for developing active TB; however, little is known about the interaction of GDM, HIV and TB. We review the epidemiology and immunology of GDM, and significant research gaps in understanding the interactions between GDM, pregnancy, and TB in women living with and those without HIV.